Clinical trial
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With…
NCT00004917 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00004917 |
|---|---|
| Title | Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer |
| Official title | A Randomized Phase III Trial to Assess the Effect of Erythropoietin on Local-Regional Control in Anemic Patients Treated With Radiotherapy for Carcinoma of the Head and Neck |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Head and Neck Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | epoetin alfa, cisplatin, radiation therapy |
| Start date | Jun 1, 2000 |
| Primary completion | Nov 1, 2007 |
| Completion | Dec 1, 2016 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 22, 2020 |
| Countries | Canada, South Korea, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: